Literature DB >> 16971886

State-specific prevalence of obesity among adults--United States, 2005.

.   

Abstract

Obesity, one of the 10 leading U.S. health indicators, is associated with increased risk for hypertension, dyslipidemia, type 2 diabetes, coronary heart disease, stroke, and certain cancers. A Healthy People 2010 objective is to reduce to 15% the prevalence of obesity among adults in the United States (objective 19-2). Both national-level data from the National Health and Nutrition Examination Survey (NHANES) and state-level data from the Behavioral Risk Factor Surveillance System (BRFSS) indicate that the prevalence of obesity among adults continued to increase during the past decade. In 2003, one study estimated that state-specific, obesity-attributable medical expenditures ranged from $87 million in Wyoming to $7.7 billion in California. To assess the prevalence of obesity among adults by state and demographic characteristics since 1995, data were analyzed from the 1995, 2000, and 2005 BRFSS surveys. The results of these analyses indicated that 23.9% of U.S. adults were obese in 2005, and the prevalence of obesity increased during 1995-2005 in all states. To reverse this trend, a sustained and effective public health response is needed, including surveillance, research, policies, and programs directed at improving environmental factors, increasing awareness, and changing behaviors to increase physical activity and decrease calorie intake.

Entities:  

Mesh:

Year:  2006        PMID: 16971886

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  52 in total

1.  Patterns and correlates of multiple risk behaviors in overweight women.

Authors:  Alvaro Sanchez; Gregory J Norman; James F Sallis; Karen J Calfas; Cheryl Rock; Kevin Patrick
Journal:  Prev Med       Date:  2007-10-18       Impact factor: 4.018

2.  Assessment of male anthropometric trends and the effects on simulated heat stress responses.

Authors:  Miyo Yokota; Gaston P Bathalon; Larry G Berglund
Journal:  Eur J Appl Physiol       Date:  2008-01-15       Impact factor: 3.078

Review 3.  Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Am J Ther       Date:  2009 Jul-Aug       Impact factor: 2.688

4.  A clinical nutrition course to improve pharmacy students' skills and confidence in counseling patients.

Authors:  Linda Chang; Nicholas G Popovich; Cherdsak Iramaneerat; Everett V Smith; M Nawal Lutfiyya
Journal:  Am J Pharm Educ       Date:  2008-06-15       Impact factor: 2.047

Review 5.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

6.  Keeping a Step Ahead: formative phase of a workplace intervention trial to prevent obesity.

Authors:  Jane Zapka; Stephenie C Lemon; Barbara B Estabrook; Denise G Jolicoeur
Journal:  Obesity (Silver Spring)       Date:  2007-11       Impact factor: 5.002

Review 7.  Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Authors:  Mark F Munsell; Brian L Sprague; Donald A Berry; Gary Chisholm; Amy Trentham-Dietz
Journal:  Epidemiol Rev       Date:  2014       Impact factor: 6.222

Review 8.  The gut in the brain: the effects of bariatric surgery on alcohol consumption.

Authors:  Ashley N Blackburn; Andras Hajnal; Lorenzo Leggio
Journal:  Addict Biol       Date:  2016-08-31       Impact factor: 4.280

9.  Obesity among patients with HIV: the latest epidemic.

Authors:  Nancy Crum-Cianflone; Raechel Tejidor; Sheila Medina; Irma Barahona; Anuradha Ganesan
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

10.  Do obese adults have a higher risk of asthma attack when exposed to indoor mold? A study based on the 2005 Behavioral Risk Factor Surveillance System.

Authors:  Xiao-Jun Wen; Lina Balluz; Ali Mokdad
Journal:  Public Health Rep       Date:  2009 May-Jun       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.